3rd Quarter - Report
MERCURY PUBLIC AFFAIRS, LLC for KYTHERA BIOPHARMACEUTICALS, INC
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical compounding. S. 959, Pharmaceutical Quality, Security, and Accountability Act; H. R. 3204, Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN ELIAS | — |
| ED KUTLER | — |
| ERICK C. MULLEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.